Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001683168-23-002379
Filing Date
2023-04-14
Accepted
2023-04-14 09:58:36
Documents
47
Period of Report
2023-02-28

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT cnbx_i10q-022823.htm   iXBRL 10-Q 478248
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER cnbx_ex3101.htm EX-31.1 10107
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER cnbx_ex3102.htm EX-31.2 10189
4 CERTIFICATION cnbx_ex3201.htm EX-32.1 5015
5 CERTIFICATION cnbx_ex3202.htm EX-32.2 4939
6 GRAPHIC image_001.jpg GRAPHIC 20350
7 GRAPHIC image_001.gif GRAPHIC 8866
8 GRAPHIC image_002.jpg GRAPHIC 22740
9 GRAPHIC image_003.jpg GRAPHIC 12963
10 GRAPHIC image_004.jpg GRAPHIC 37075
11 GRAPHIC image_004.gif GRAPHIC 10528
12 GRAPHIC image_005.jpg GRAPHIC 38054
13 GRAPHIC image_006.jpg GRAPHIC 46524
14 GRAPHIC image_007.jpg GRAPHIC 5007
15 GRAPHIC image_008.jpg GRAPHIC 43146
16 GRAPHIC image_009.jpg GRAPHIC 8586
17 GRAPHIC image_009.gif GRAPHIC 13157
18 GRAPHIC image_010.jpg GRAPHIC 2191
  Complete submission text file 0001683168-23-002379.txt   2467631

Data Files

Seq Description Document Type Size
19 XBRL SCHEMA FILE cnbx-20230228.xsd EX-101.SCH 12276
20 XBRL CALCULATION FILE cnbx-20230228_cal.xml EX-101.CAL 24381
21 XBRL DEFINITION FILE cnbx-20230228_def.xml EX-101.DEF 21699
22 XBRL LABEL FILE cnbx-20230228_lab.xml EX-101.LAB 116155
23 XBRL PRESENTATION FILE cnbx-20230228_pre.xml EX-101.PRE 86309
41 EXTRACTED XBRL INSTANCE DOCUMENT cnbx_i10q-022823_htm.xml XML 126764
Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429
CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)

EIN.: 203373669 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 10-Q | Act: 34 | File No.: 000-52403 | Film No.: 23820031
SIC: 2834 Pharmaceutical Preparations